How convenient would it be if you could diagnose your health condition in seconds with a simple device, without even visiting a hospital? Artificial intelligence (AI) medical diagnostic technology is making this dream a reality. As AI's growth accelerates recently, it is bringing immense changes to the medical field. However, behind this technological advancement, complex issues such as ethics, trust, and data bias also exist. Even at this moment, we are at a juncture where we must discuss both the possibilities and limitations offered by AI medical diagnosis. A deep-dive analytical project, scheduled to be published by MIT Technology Review in late April 2026, will shed light on the ethical and social issues arising from the rapid development of AI-based medical diagnostic technology. The core question posed by this project is clear: Despite the high efficiency offered by AI medical diagnosis, how will we address issues such as data bias, algorithmic opacity, changes in the patient-doctor trust relationship, and imbalances in healthcare accessibility? AI medical diagnostic technology is gaining attention for its accuracy. Numerous studies report that AI-based diagnostic systems perform on par with or even surpass the judgment of existing medical professionals in specific disease areas. Particularly in the field of radiology, AI demonstrates excellent capabilities in analyzing medical images to detect cancer, cardiovascular diseases, and neurological disorders early. These technologies offer advantages such as reducing the workload of medical staff, accelerating diagnosis, and being applicable even in regions with limited medical resources. For instance, according to several studies published in international medical technology journals, AI has significantly lowered false-positive rates while improving detection rates in breast cancer screening. Furthermore, in the diagnosis of diabetic retinopathy, there are reports that AI-based screening tests are contributing to blindness prevention in developing countries where ophthalmologists are scarce. These achievements demonstrate the potential of AI medical diagnostic technology to save patients' lives and improve their quality of life. However, there are not only positive effects. The rapid development of AI medical diagnostic technology is leading to ethical dilemmas. AI, trained on large datasets, has the potential to inherit biases present in that data. Several studies point out that AI diagnostic technology may show lower accuracy in certain population groups compared to others. This problem arises when medical data is collected primarily from specific genders, races, or age groups, or is biased towards data from particular medical institutions. Indeed, a research team at Stanford University in the United States published findings indicating that AI for skin cancer diagnosis, primarily trained on images of skin lesions from white patients, tends to inaccurately diagnose skin cancer in patients of color. Similarly, there are studies showing that ECG analysis AI exhibits higher error rates in specific genders or age groups. This increases the likelihood of certain patient groups receiving inaccurate diagnoses, which could exacerbate health inequalities. International health organizations, including the World Health Organization (WHO), emphasize the diversity and standardization of medical data to address such issues. However, fully implementing this globally requires significant time and resources. Especially in developing countries, where medical data infrastructure is often insufficient or not standardized, securing suitable data for AI training is challenging. Another significant issue is the lack of algorithmic transparency. The technical background of AI medical diagnosis is opaque, like a black box, not only to the general public but also to many medical professionals. Deep learning algorithms learn complex patterns through millions of parameters, and in this process, it is often difficult to clearly explain the basis on which the algorithm makes a particular diagnosis. Ethical Dilemmas and Data Bias Issues This opacity creates practical problems in clinical settings. Medical professionals often distrust AI's diagnostic results, and patients frequently place more trust in a human doctor's judgment than in data-driven algorithms. Furthermore, legal and ethical debates exist regarding who should bear responsibility when AI makes a misdiagnosis. Medical AI researchers are striving to develop Explainable AI (XAI), but it has not yet reached a sufficient level. Medical ethicists at Johns Hopkins School of Medicine point out, 'No matter how advanced AI technology is, the moment it betrays the trust between patient and doctor, it inevitably acts as an obstacle rather than a medical innovation.' This emphasizes that social acceptance and trust-building are as crucial as technical accuracy. Where does the Korean medical market stand amidst these changes? Current
Related Articles